Munich Reinsurance Co Stock Corp in Munich Buys New Shares in HCA Healthcare, Inc. $HCA

Munich Reinsurance Co Stock Corp in Munich purchased a new position in shares of HCA Healthcare, Inc. (NYSE:HCA) in the third quarter, HoldingsChannel reports. The fund purchased 5,569 shares of the company’s stock, valued at approximately $2,374,000.

A number of other large investors have also recently bought and sold shares of the company. Angeles Wealth Management LLC boosted its position in HCA Healthcare by 2.4% in the third quarter. Angeles Wealth Management LLC now owns 1,014 shares of the company’s stock valued at $432,000 after buying an additional 24 shares during the last quarter. Evexia Wealth LLC boosted its holdings in shares of HCA Healthcare by 16.7% in the 3rd quarter. Evexia Wealth LLC now owns 18,046 shares of the company’s stock valued at $7,411,000 after acquiring an additional 2,589 shares during the last quarter. First Trust Advisors LP raised its holdings in shares of HCA Healthcare by 46.5% during the third quarter. First Trust Advisors LP now owns 127,552 shares of the company’s stock worth $54,363,000 after purchasing an additional 40,476 shares during the last quarter. HUB Investment Partners LLC boosted its holdings in HCA Healthcare by 42.1% in the third quarter. HUB Investment Partners LLC now owns 1,685 shares of the company’s stock valued at $718,000 after purchasing an additional 499 shares during the last quarter. Finally, Modern Wealth Management LLC raised its stake in shares of HCA Healthcare by 4.5% during the 3rd quarter. Modern Wealth Management LLC now owns 610 shares of the company’s stock valued at $260,000 after buying an additional 26 shares during the last quarter. Hedge funds and other institutional investors own 62.73% of the company’s stock.

Insider Transactions at HCA Healthcare

In related news, SVP Jennifer Berres sold 8,020 shares of the business’s stock in a transaction dated Wednesday, February 11th. The shares were sold at an average price of $514.58, for a total transaction of $4,126,931.60. Following the transaction, the senior vice president directly owned 11,993 shares in the company, valued at approximately $6,171,357.94. The trade was a 40.07% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, EVP Michael R. Mcalevey sold 1,694 shares of the firm’s stock in a transaction that occurred on Wednesday, February 18th. The stock was sold at an average price of $533.37, for a total transaction of $903,528.78. Following the completion of the transaction, the executive vice president directly owned 8,853 shares in the company, valued at $4,721,924.61. This trade represents a 16.06% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders sold a total of 15,214 shares of company stock valued at $7,797,595 in the last 90 days. 1.30% of the stock is owned by company insiders.

Analyst Upgrades and Downgrades

HCA has been the topic of several analyst reports. Argus raised their target price on HCA Healthcare from $530.00 to $560.00 and gave the stock a “buy” rating in a report on Friday, February 6th. Royal Bank Of Canada raised their price objective on shares of HCA Healthcare from $525.00 to $555.00 and gave the stock an “outperform” rating in a research note on Wednesday, January 28th. Mizuho increased their price target on shares of HCA Healthcare from $540.00 to $585.00 and gave the stock an “outperform” rating in a report on Wednesday, February 25th. Robert W. Baird lifted their price objective on shares of HCA Healthcare from $423.00 to $450.00 and gave the company a “neutral” rating in a report on Thursday, December 11th. Finally, Deutsche Bank Aktiengesellschaft raised their target price on HCA Healthcare from $500.00 to $558.00 and gave the company a “buy” rating in a research report on Wednesday, January 28th. Sixteen investment analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has given a Sell rating to the stock. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus price target of $534.50.

Key Stories Impacting HCA Healthcare

Here are the key news stories impacting HCA Healthcare this week:

• Positive Sentiment: Analyst sentiment and research upgrades: several outlets and analysts continue to rate HCA favorably — one consensus snapshot called the stock a “Moderate Buy,” reflecting continued analyst confidence that HCA can grow earnings and return capital to shareholders. Article Title
• Positive Sentiment: Long-term demographic bull case: MarketBeat argues HCA is a likely beneficiary of U.S. aging demographics, noting management’s strong guidance (FY2026 EPS and EBITDA ranges), expanded capex, a $10B repurchase authorization and a raised dividend — all supportive of long?term growth and shareholder returns. Article Title
• Neutral Sentiment: Analyst estimate tweaks from Zacks: Zacks Research nudged near?term EPS estimates slightly higher for Q2, Q3 and Q4 2026 and raised FY2026 to $29.63, which supports the earnings outlook, but it kept a “Hold” rating — a modest positive but not a strong endorsement. Article Title
• Neutral Sentiment: Zacks’ view is mixed farther out: while FY2026 estimates were lifted, Zacks trimmed its FY2028 EPS forecast modestly — a sign analysts see near?term strength but some uncertainty on longer?term margin expansion. Article Title
• Neutral Sentiment: Local/industry headlines are mixed and mostly non?company specific: a local hospital (Manchester’s Catholic Medical Center) plans to end outpatient mental?health services and a leadership hire at Methodist Healthcare were reported — signals about regional capacity and staffing but with limited direct impact on HCA’s large national footprint. Article Title Article Title
• Negative Sentiment: Near?term policy and revenue risks remain prominent: recent company commentary and market writeups note revenue growth was slightly below expectations in the prior quarter and management flagged $600–$900M of potential EBITDA headwinds from insurance?exchange changes plus state supplemental payment declines — factors that could cap near?term upside despite strong EPS. Article Title

HCA Healthcare Stock Performance

NYSE:HCA opened at $533.63 on Friday. The company has a fifty day moving average of $500.34 and a two-hundred day moving average of $465.40. HCA Healthcare, Inc. has a fifty-two week low of $310.18 and a fifty-two week high of $552.90. The stock has a market capitalization of $119.33 billion, a PE ratio of 18.80, a P/E/G ratio of 1.64 and a beta of 1.34.

HCA Healthcare (NYSE:HCA) last released its earnings results on Tuesday, January 27th. The company reported $8.01 EPS for the quarter, topping analysts’ consensus estimates of $7.37 by $0.64. HCA Healthcare had a net margin of 8.97% and a negative return on equity of 409.11%. The business had revenue of $19.51 billion during the quarter, compared to analysts’ expectations of $19.67 billion. During the same quarter in the previous year, the company earned $6.22 earnings per share. The company’s quarterly revenue was up 6.7% on a year-over-year basis. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. Research analysts forecast that HCA Healthcare, Inc. will post 24.98 earnings per share for the current year.

HCA Healthcare Increases Dividend

The company also recently declared a quarterly dividend, which will be paid on Tuesday, March 31st. Stockholders of record on Tuesday, March 17th will be paid a $0.78 dividend. This is a boost from HCA Healthcare’s previous quarterly dividend of $0.72. This represents a $3.12 dividend on an annualized basis and a dividend yield of 0.6%. The ex-dividend date of this dividend is Tuesday, March 17th. HCA Healthcare’s dividend payout ratio is presently 10.99%.

About HCA Healthcare

HCA Healthcare is a for?profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.